Home
Forms Library
Contains Nonbinding Recommendations Guidance on Famotidine This guidance represents the Food and Dru

Contains Nonbinding Recommendations Guidance on Famotidine This guidance represents the Food and Dru 2025

Contains Nonbinding Recommendations Guidance on Famotidine This guidance represents the Food and Dru Preview on Page 1

Show details

4.4 out of 5

33 votes

The document provides nonbinding guidance from the FDA regarding the use of Famotidine, specifically for oral tablets. It outlines recommended studies for establishing bioequivalence, including fasting and fed conditions with a focus on 40 mg strength. It also discusses waiver requests for in-vivo testing for lower strengths based on acceptable studies and dissolution testing. The guidance emphasizes that separate applications are needed for prescription and over-the-counter products.

Here's how it works

01. Edit your form online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send it via email, link, or fax. You can also download it, export it or print it out.

How to rapidly redact Contains Nonbinding Recommendations Guidance on Famotidine This guidance represents the Food and Dru online

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Dochub is the greatest editor for modifying your documents online. Adhere to this simple guide to redact Contains Nonbinding Recommendations Guidance on Famotidine This guidance represents the Food and Dru in PDF format online at no cost:

Sign up and sign in. Register for a free account, set a strong password, and go through email verification to start managing your forms.
Upload a document. Click on New Document and select the file importing option: upload Contains Nonbinding Recommendations Guidance on Famotidine This guidance represents the Food and Dru from your device, the cloud, or a secure URL.
Make changes to the sample. Take advantage of the upper and left-side panel tools to redact Contains Nonbinding Recommendations Guidance on Famotidine This guidance represents the Food and Dru. Add and customize text, images, and fillable fields, whiteout unneeded details, highlight the important ones, and provide comments on your updates.
Get your paperwork completed. Send the form to other people via email, create a link for faster file sharing, export the sample to the cloud, or save it on your device in the current version or with Audit Trail added.

Discover all the benefits of our editor today!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

What is the new warning on famotidine?

The US Food and Drug Administration and Health Canada have issued a warning to change the dose and dosing intervals of famotidine in patients with severe or moderate renal failure. Famotidine, a histamine H2 receptor antagonist used mainly to treat peptic ulcer disease, is excreted almost exclusively by the kidneys.

Which is safer long term, omeprazole or famotidine?

The risks associated with being on PPIs such as omeprazole long-term are more concrete than the risks of being on famotidine long-term. The most concrete possible risks of being on omeprazole long-term are vitamin and mineral deficiencies.

What is the FDA guidance on solubility?

The solubility of a drug is determined by dissolving the highest unit dose of the drug in 250 mL of buffer adjusted between pH 1.0 and 8.0. A drug substance is considered highly soluble when the dose/solubility volume of solution are less than or equal to 250 mL.

What are the FDA solvent classes?

The guidance divides solvents into three risk-based classes: Class 1 solvents, which are known to cause unacceptable toxicities; Class 2 solvents, which are associated with less severe toxicity; and Class 3 solvents, which have low toxic potential.

What is the guidance for famotidine?

GERD with erosive esophagitis: The recommended famotidine dosage ranges from 20 to 40 mg taken orally twice daily, with a treatment duration of up to 12 weeks. Alternatively, an IV dosage of 20 mg every 12 hours can be considered.

Has famotidine been taken off the market?

We have found no information that would indicate that this drug product was withdrawn from sale for reasons of safety or effectiveness. ingly, the Agency will continue to list PEPCID (famotidine) for oral suspension, 40 mg/5 mL, in the Discontinued Drug Product List section of the Orange Book.

What organ does famotidine affect?

It works by decreasing the amount of acid produced by the stomach. This medicine is available with your doctors prescription and also without a prescription. For the prescription form, there is more medicine in each tablet.

What are the FDA recommendations for dissolution?

FDA generally recommends that by the last sampling time, at least 70-85% (Q) of the labeled content of the active drug should be dissolved, depending upon the specific drug product.

What is good solubility for a drug?

Solubility is based on the highest-dose strength of an immediate release product. A drug is considered highly soluble when the highest dose strength is soluble in 250 mL or less of aqueous media over the pH range of 1 to 7.5.

What is the solubility as per ICH guidelines?

Drug Solubility. ing to the ICH solubility criteria, a drug substance is considered highly soluble if the highest single therapeutic dose is completely soluble in 250 mL or less of aqueous media in the pH range of 1.2 to 6.8 at 37 C.

Contains Nonbinding Recommendations Guidance on Famotidine This guidance represents the Food and Dru 2025

Here's how it works